65 related articles for article (PubMed ID: 24383078)
21. Contribution of the hydrophobicity gradient of an amphipathic peptide to its mode of association with lipids.
Pérez-Méndez O; Vanloo B; Decout A; Goethals M; Peelman F; Vandekerckhove J; Brasseur R; Rosseneu M
Eur J Biochem; 1998 Sep; 256(3):570-9. PubMed ID: 9780233
[TBL] [Abstract][Full Text] [Related]
22. Structural and functional properties of natural and chemical variants of apolipoprotein A-I.
Jonas A; von Eckardstein A; Churgay L; Mantulin WW; Assmann G
Biochim Biophys Acta; 1993 Feb; 1166(2-3):202-10. PubMed ID: 8443238
[TBL] [Abstract][Full Text] [Related]
23. [A turning point in the knowledge of the structure-function-activity relations of elastin].
Alix AJ
J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
[TBL] [Abstract][Full Text] [Related]
24. A mechanistic model of lecithin:cholesterol acyltransferase activity exploits discoidal HDL composition and structure.
Dergunov AD
Arch Biochem Biophys; 2012 Apr; 520(2):81-7. PubMed ID: 22381956
[TBL] [Abstract][Full Text] [Related]
25. Two different allelic mutations in the lecithin-cholesterol acyltransferase gene associated with the fish eye syndrome. Lecithin-cholesterol acyltransferase (Thr123----Ile) and lecithin-cholesterol acyltransferase (Thr347----Met).
Klein HG; Lohse P; Pritchard PH; Bojanovski D; Schmidt H; Brewer HB
J Clin Invest; 1992 Feb; 89(2):499-506. PubMed ID: 1737840
[TBL] [Abstract][Full Text] [Related]
26. Plasma lecithin:cholesterol acyltransferase activity in hypophysectomized rats.
Manninen V; Mälkönen M; Blomhoff JP; Gjone E
Scand J Clin Lab Invest Suppl; 1978; 150():147-50. PubMed ID: 218273
[TBL] [Abstract][Full Text] [Related]
27. Studies of synthetic peptides of human apolipoprotein A-I containing tandem amphipathic alpha-helixes.
Mishra VK; Palgunachari MN; Datta G; Phillips MC; Lund-Katz S; Adeyeye SO; Segrest JP; Anantharamaiah GM
Biochemistry; 1998 Jul; 37(28):10313-24. PubMed ID: 9665740
[TBL] [Abstract][Full Text] [Related]
28. Apolipoprotein A-I helix 6 negatively charged residues attenuate lecithin-cholesterol acyltransferase (LCAT) reactivity.
Alexander ET; Bhat S; Thomas MJ; Weinberg RB; Cook VR; Bharadwaj MS; Sorci-Thomas M
Biochemistry; 2005 Apr; 44(14):5409-19. PubMed ID: 15807534
[TBL] [Abstract][Full Text] [Related]
29. Deletion of specific glycan chains affects differentially the stability, local structures, and activity of lecithin-cholesterol acyltransferase.
Kosman J; Jonas A
J Biol Chem; 2001 Oct; 276(40):37230-6. PubMed ID: 11486003
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the haptoglobin binding region on the apolipoprotein A-I-derived P2a peptide.
Spagnuolo MS; Di Stasi R; De Rosa L; Maresca B; Cigliano L; D'Andrea LD
J Pept Sci; 2013 Apr; 19(4):220-6. PubMed ID: 23420675
[TBL] [Abstract][Full Text] [Related]
31. Dietary nucleotides enhance plasma lecithin cholesterol acyl transferase activity and apolipoprotein A-IV concentration in preterm newborn infants.
Sánchez-Pozo A; Ramírez M; Gil A; Maldonado J; van Biervliet JP; Rosseneu M
Pediatr Res; 1995 Mar; 37(3):328-33. PubMed ID: 7784143
[TBL] [Abstract][Full Text] [Related]
32. Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency.
Simonelli S; Tinti C; Salvini L; Tinti L; Ossoli A; Vitali C; Sousa V; Orsini G; Nolli ML; Franceschini G; Calabresi L
Biologicals; 2013 Nov; 41(6):446-9. PubMed ID: 24140107
[TBL] [Abstract][Full Text] [Related]
33. Mechanism and Physiologic Significance of the Suppression of Cholesterol Esterification in Human Interstitial Fluid.
Miller NE; Olszewski WL; Miller IP; Nanjee MN
Front Pharmacol; 2016; 7():216. PubMed ID: 27471469
[TBL] [Abstract][Full Text] [Related]
34. Chain length-function correlation of amphiphilic peptides. Synthesis and surface properties of a tetratetracontapeptide segment of apolipoprotein A-I.
Fukushima D; Yokoyama S; Kroon DJ; Kézdy FJ; Kaiser ET
J Biol Chem; 1980 Nov; 255(22):10651-7. PubMed ID: 6776121
[TBL] [Abstract][Full Text] [Related]
35. A new enzyme-linked immunosorbent assay with two monoclonal antibodies to specific epitopes measures human lecithin-cholesterol acyltransferase.
Kobori K; Saito K; Ito S; Kotani K; Manabe M; Kanno T
J Lipid Res; 2002 Feb; 43(2):325-34. PubMed ID: 11861675
[TBL] [Abstract][Full Text] [Related]
36. Contribution of the hydrophobicity gradient to the secondary structure and activity of fusogenic peptides.
Decout A; Labeur C; Vanloo B; Goethals M; Vandekerckhove J; Brasseur R; Rosseneu M
Mol Membr Biol; 1999; 16(3):237-46. PubMed ID: 10503245
[TBL] [Abstract][Full Text] [Related]
37. Native like structure and stability of apo AI in a n-propanol/water solution as determined by 13C NMR.
Leroy A; Lippens G; Wieruszeski JM; Parra HJ; Fruchart JC
FEBS Lett; 1995 Mar; 361(1):29-34. PubMed ID: 7890036
[TBL] [Abstract][Full Text] [Related]
38. Microenvironmentally controlled secondary structure motifs of apolipoprotein A-I derived peptides.
Mendoza-Espinosa P; Montalvan-Sorrosa D; García-González V; Moreno A; Castillo R; Mas-Oliva J
Mol Cell Biochem; 2014 Aug; 393(1-2):99-109. PubMed ID: 24748322
[TBL] [Abstract][Full Text] [Related]
39. Human apo A-I in transgenic mice is more efficient in activating lecithin:cholesterol acyltransferase than mouse apo A-I.
Golder-Novoselsky E; Nichols AV; Rubin EM; Forte TM
Biochim Biophys Acta; 1995 Jan; 1254(2):217-20. PubMed ID: 7827127
[TBL] [Abstract][Full Text] [Related]
40. Crystallization of truncated human apolipoprotein A-I in a novel conformation.
Borhani DW; Engler JA; Brouillette CG
Acta Crystallogr D Biol Crystallogr; 1999 Sep; 55(Pt 9):1578-83. PubMed ID: 10489452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
